monoclonal-antibody

Documents about monoclonal-antibody

• A Study of Paclitaxel/Carboplatin With or Without CDP791 in Patients With Lung Cancer#882413ClinicalTrials.gov
• Monoclonal Antibody Therapy in Treating Patients With Advanced Cancer#993892ClinicalTrials.gov
• Simtuzumab (SIM, GS-6624) in the Treatment of Cirrhosis Due to NASH#870460ClinicalTrials.gov
• Clinical Trial to Evaluate Efficacy and Safety of Acellbia® (JSC "BIOCAD") With Methotrexate in First Line Biological Therapy of Patients With Active Rheumatoid Arthritis#883940ClinicalTrials.gov
• Phase IIa Study of Multiple Doses of AbGn-168H by iv Infusion in Moderate to Severe Chronic Plaque Psoriasis Patients#893031ClinicalTrials.gov
• Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy#915419ClinicalTrials.gov
• Relaxation Processes in Freeze-Dried Monoclonal Antibody–Sucrose Formulations: The Role of Water Content#403921Figshare
• Evaluating the Safety and Serum Concentrations of a Human Monoclonal Antibody, VRC-HIVMAB075-00-AB (VRC07-523LS), Administered in Multiple Doses and Routes to Healthy, HIV-uninfected Adults#424233ClinicalTrials.gov
• Development of a novel histidine-rich glycoprotein measurement system as a biomarker for sepsis#428152OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• Higher vs Standard Adalimumab Induction and Maintenance Dosing Regimens for Treatment of Ulcerative Colitis: SERENE UC Trial Results#643352HAL (France)
• Second-season Impact of Nirsevimab: Clinical Outcomes of RSV Disease in Patients Immunized During Their First Season.#672219Repisalud
• A Open Label, Dose Escalating Study to Evaluate the Safety and Tolerability of Ascending Intravenous (i.v.) Doses of Catumaxomab in Epithelial Cancer Patients#831875ClinicalTrials.gov
• Assessing the Drug Exposure Risk of Infants Breastfed by Women With Inflammatory Bowel Disease#838190ClinicalTrials.gov
• A Phase 1b Study With Volociximab in Combination With Carboplatin, Paclitaxel, and Bevacizumab in First-line, Advanced Non-small Cell Lung Cancer (NSCLC)#875878ClinicalTrials.gov
• Study of 177Lu Human Monoclonal Antibody 5B1 (MVT-1075) in Combination With a Blocking Dose of MVT-5873 as Radioimmunotherapy#901432ClinicalTrials.gov
• A Real-world Study Comparing the Effectiveness of Ofatumumab and Ocrelizumab Treatment in Multiple Sclerosis Patients#915891ClinicalTrials.gov
• Monoclonal antibody levels and protection from COVID-19#201390UNSWorks Repository
• Deciphering the Impact of HER2 Alterations on Non-Small-Cell Lung Cancer: From Biological Mechanisms to Therapeutic Approaches#215401HAL (France)
• A Pospective, Single-arm, Multicenter Clinical Trial Evaluating Preoperative Neoadjuvant mFOLFOX6 Chemotherapy in Combination With PD1 Monoclonal Antibody in MSS/pMMR Locally Advanced Rectal Cancer#261515ClinicalTrials.gov
• Study of Radiolabeled Monoclonal Antibody Anti-B1 for the Treatment of B-Cell Lymphomas and Extended Study to Determine the Safety and Efficacy of Coulter Clone® 131Iodine-B1 Radioimmunotherapy of Advanced Non-Hodgkin's Lymphoma#300238ClinicalTrials.gov
• Safety and Tolerability of a mRNA Vaccine Encoding Tumor-Specific Circular RNA Antigens in Combination With Anti-PD-1 Monoclonal Antibody in Patients With Advanced Solid Tumors#417531ClinicalTrials.gov
• Safety of TY027, a Treatment for COVID-19, in Humans#830242ClinicalTrials.gov
• A Study Evaluating the Safety, Tolerability, and Initial Efficacy of Recombinant Human Anti-cluster Differentiation Antigen 47 (CD47) Monoclonal Antibody Injection (IBI188) in Patients With Advanced Malignant Tumors and Lymphomas#860591ClinicalTrials.gov
• Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid in Combination With Polatuzumab (ViPOR-P) in Relapsed/Refractory B-cell Lymphoma#902095ClinicalTrials.gov
• Venetoclax With Obinutuzumab and Magrolimab (VENOM) in Relapsed and Refractory Indolent B-cell Malignancies#905710ClinicalTrials.gov
• Chemotherapy and Peripheral Stem Cell Transplant With or Without Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma#907176ClinicalTrials.gov
• A Prospective, Single-Arm, Phase II Study: PD-L1 Monoclonal Antibody + Chemoradiotherapy as Bridge Therapy to Liver Transplantation for Locally Advanced Perihilar Cholangiocarcinoma (ACHIEVE-LT)#981873ClinicalTrials.gov
• Therapeutic Efficacy of Monoclonal Antibody Drugs for Alzheimer's Disease Based on PET Research#993763ClinicalTrials.gov
• S0354, Anti-IL-6 Chimeric Monoclonal Antibody in Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy#994082ClinicalTrials.gov
• Monoclonal Antibody Plus Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes#826359ClinicalTrials.gov
• Radiolabeled Monoclonal Antibody Therapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Breast Cancer#847770ClinicalTrials.gov
• Tolerability and Safety of Vemurafenib, Cetuximab Combined With Camrelizumab for BRAF V600E-mutated /MSS Metastatic Colorectal Cancer#860182ClinicalTrials.gov
• Phase III Randomized Study of Anti-Tumor Necrosis Factor Chimeric Monoclonal Antibody (cA2) for Patients With Enterocutaneous Fistulae as a Complication of Crohn's Disease#877524ClinicalTrials.gov
• Cholesterol Disruption in Combination With the Standard of Care in Patients With Advanced Pancreatic Adenocarcinoma#1033649ClinicalTrials.gov
• Lower But More Frequent Dose Rituximab to Treat Chronic Lymphocytic Leukemia#811687ClinicalTrials.gov
• Avelumab for People With Recurrent Respiratory Papillomatosis#812249ClinicalTrials.gov
• A Phase I Imaging and Pharmacodynamic Trial of CS-1008 in Patients With Metastatic Colorectal Cancer#837697ClinicalTrials.gov
• The Efficacy of Two Potential Diagnostic Assays for Herpes Simplex Keratitis (HSK)#839455ClinicalTrials.gov
• Phase I/II Clinical Trial of Axatilimab, a CSF1R Monoclonal Antibody, in Combination With Ruxolitinib as Therapy for Patients With Myelofibrosis (MF) and Chronic Myelomonocytic Leukemia (CMML)#841838ClinicalTrials.gov
• Ramucirumab or Anti-PDGFR Alpha Monoclonal Antibody IMC-3G3 in Treating Patients With Recurrent Glioblastoma Multiforme#850497ClinicalTrials.gov
• Intraperitoneal Paclitaxel and Carboplatin With IV Avastin Therapy in Patients With Carcinomas of Mullerian Origin#884790ClinicalTrials.gov
• A Phase 3 Study of Siltuximab or Placebo in Combination With Velcade and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma#903274ClinicalTrials.gov
• A First Time in Human (FTIH) Study of GSK3745417 Administered to Participants With Advanced Solid Tumors#800662ClinicalTrials.gov
• Study of Brentuximab Vedotin in Participants With Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma#846912ClinicalTrials.gov
• A Study of MK-6072 and MK-3415A in Participants Receiving Antibiotic Therapy for Clostridium Difficile Infection (MK-3415A-002)#887007ClinicalTrials.gov
• Study of Cisplatin/Vinorelbine +/- Cetuximab as First-line Treatment of Advanced Non Small Cell Lung Cancer (FLEX)#912538ClinicalTrials.gov
• A Trial to Learn if REGN7999 is Safe and Well Tolerated, and How it Works in the Body of Healthy Participants#914971ClinicalTrials.gov
• Elezanumab, a human anti-RGMa monoclonal antibody, promotes neuroprotection, neuroplasticity, and neurorecovery following a thoracic hemicompression spinal cord injury in non-human primates#388254Infoscience
• Recombinant Human Adenovirus Type 5 Injection Combined With PD-1 Monoclonal Antibody and Nab-paclitaxel in the Treatment of Patients With Liver Metastases From Malignant Melanoma#880178ClinicalTrials.gov
• Contribution of Anti-platelet Antibodies Identified With MAIPA Assay in the Demonstration of the Auto-immune Character of a Thrombocytopenia at Diagnosis#883173ClinicalTrials.gov